GLP-1 analogues have changed the treatment of obesity and cardiometabolic risk. But they have also generated a lot of noise: unreal expectations, use without follow-up and the idea that "medication replaces habits."
They are an effective tool to treat obesity in the people for whom they are indicated. The accompaniment allows you to take advantage of the reduction of appetite, care for nutrition and maintain physical capacity during the process.
Take advantage of the change of appetite to build a plan that nourishes you well, takes care of the muscle and has continuity.
What are GLP-1 analogues (easy explained)
GLP-1 is a hormone involved in regulating appetite and blood glucose. GLP-1 analogues, or receptor agonists (and some dual-acting medicines), mimic part of this effect.
In practice, they tend to:
- Reduce hunger and increase satiety.
- Influence blood glucose regulation.
- Delay stomach emptying, especially at certain stages of treatment.
When treatment is evaluated
The indication depends on the medicine, the clinical history and goals. In adults, some are authorised for obesity or overweight with weight-related health conditions. Others have specific indications for diabetes.
The consultation provides an opportunity to review your medical history, treatments, diet and expectations. Cost, availability and how long treatment is expected to continue are also discussed. Needing medication is not a personal failure: it is one of the options for treating a chronic condition.
What changes are worth following
In general, the drug may facilitate:
- Reduction of energy intake
- Weight loss
- Improvement of metabolic markers in certain profiles
In addition to weight, it is important to follow the relevant waist, strength, well-being and clinical results.
- Keep muscle and function: combine adequate nutrition and adapted training.
- Prepare maintenance: agree from the outset how the continuity of treatment and support will be reviewed.
Costs and side effects (what to know)
The most common are digestive:
- Nausea, feeling of fullness
- Constipation or diarrhoea
- Reflux, burps
- Reduced tolerance of very fatty or large meals
Risks and precautions depend on your medical history and medication, so follow-up with a doctor is essential.
Expected benefits vs costs and risks
A summary to assess the decision with clear information:
To understand better
Two objectives that move together
Improving health
Weight loss, appetite control and metabolic benefits according to treatment and situation.
Maintain capacity
Nutrition, strength training, rest and monitoring how you feel and what you can do.
Practical strategy
The number 1 mistake: losing weight by eating very little
When hunger goes down a lot, it is possible to skip meals or eat amounts that do not cover what you need. Eating little does not automatically amount to eating well.
That can:
- Worsen fatigue
- Reduce performance
- Increase loss of muscle mass
- Complicate medium-term adherence
The goal is not to "eat the minimum." The goal is to eat enough, with structure.
How to integrate it into a plan that works
An approach with well-thought-out GLP-1 follows these steps:
Step by step
Treatment is an ongoing process
Starting point
Clinical history, nutritional status, strength, function and health objectives.
First weeks
Medical adjustment of the regimen and meal planning according to appetite and tolerance.
Progress
Follow-up of weight, physical ability, digestive symptoms and diet quality.
Continuity
Maintenance plan and medical decision on duration, changes or withdrawal.
To reduce side effects
Practical strategies that help better tolerate treatment:
Guidelines for improving tolerance
- Eat small portions and take more time over meals.
- Avoid very fatty or very large meals at the start.
- Prioritize easy to tolerate protein (spread throughout the day).
- Stay hydrated each day; adjust fibre intake gradually.
- Walk gently after meals if it helps.
- Do not force yourself to fast for long periods if this increases nausea or leaves you without enough protein.
- For constipation: establish a routine, drink water, move and adjust fibre intake appropriately.
What your plan should include (even if you use GLP-1)
1) Strength
Strength training helps preserve muscle and functional ability. It is adapted to your starting point: a brief, well-organised session can be a beginning.
2) Distributed protein
To support recovery, satiety and minimise lean mass loss.
3) Micronutrients and real food
Eating less means less room: you have to choose better.
4) Maintenance and monitoring
Obesity often requires ongoing care. Appetite may increase and weight may return after stopping medication, so the decision and follow-up are planned together with the team.
Questions that help take the next step
Is that cheating?
It's a medical treatment. The aim is to improve health with the resources that are appropriate for you.
What if I have little appetite?
Plan small, balanced meals. Prioritising a protein source and spreading food intake throughout the day can help meet your needs without large portions.
What if I want to stop treatment?
Talk with your doctor to plan the decision and follow-up. Maintenance may involve continuing treatment; it is not simply a matter of greater willpower.
When should I seek help with side effects?
Contact the team if nausea, constipation or diarrhoea prevent you from eating or drinking. Severe, persistent abdominal pain, repeated vomiting or signs of dehydration require prompt medical assessment.
A day of little appetite, better organized
If a large meal feels impossible, a smaller serving of yoghurt with fruit, egg on toast or fish with a side dish may work better. The aim is to distribute what is necessary, rather than waiting all day for a dinner you do not feel like eating either.
Planning your shopping helps: keep protein sources that are easy to prepare, vegetables you tolerate and drinks for hydration. Review bowel habits too. Increasing fibre gradually and keeping active is usually more comfortable than adding large amounts at once.
A look that goes beyond the weight
The 2025 professional recommendations and the 2026 European consensus highlight nutrition, physical function and wellbeing during these treatments. Bring specific examples to your reviews: doing fewer repetitions, feeling dizzy when standing up or no longer enjoying meals can all help guide adjustments.
Some medicines also benefit cardiovascular health. In the SELECT trial, semaglutide reduced major cardiovascular events by 20 % in adults with overweight or obesity and established cardiovascular disease, without diabetes. This is a reason to assess treatment in terms of health goals, as well as weight.
